Suven Life Sciences informs about outcome of board meeting

13 May 2025 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, Suven Life Sciences has informed that the Board of Directors of the company, at its meeting held today i.e. May 13, 2025, has considered and approved the following along with other business matters. Approved the Audited Standalone and Consolidated Financial Results Took on record and approved the attached Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and financial year ended March 31, 2025 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors. 

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×